FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Ceridian HCM Holding Inc. [ CDAY ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 02/28/2021 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 02/28/2021 | F | 234(1) | D | $89.66 | 68,609(2) | D |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Option (right to buy) | $17.2 | (3) | 04/27/2027 | Common Stock | 2,907 | 2,907 | D | ||||||||
Option (right to buy) | $22 | (4) | 04/25/2028 | Common Stock | 50,952 | 50,952 | D | ||||||||
Option (right to buy) | $44.91 | (5) | 02/08/2029 | Common Stock | 50,000 | 50,000 | D | ||||||||
Option (right to buy) | $44.91 | (6) | 02/08/2029 | Common Stock | 2,301 | 2,301 | D | ||||||||
Option (right to buy) | $65.26 | (7) | 05/08/2030 | Common Stock | 107,244 | 107,244 | D |
Explanation of Responses: |
1. 234 common shares forfeited to pay withholding taxes and 278 common shares issued in connection with the vesting of 512 restricted stock units on February 28, 2021. |
2. Includes (i) 31,091shares of common stock, (ii) 25,000 shares issuable pursuant to Restricted Stock Units, granted on February 8, 2019, that vest in two annual installments beginning on February 8, 2022, (ii) 1,026 shares that are issuable pursuant to Restricted Stock Units, granted on February 28, 2020, that vest in two annual installments beginning on February 28, 2022, and (iv) 11,492 shares that are issuable pursuant to Restricted Stock Units, granted on May 8, 2020, that vest in three annual installments beginning on May 8, 2021. |
3. Fully vested and exercisable. |
4. Consists of 16,984 vested and exercisable options as of April 25, 2020, and 33,968 options that vest and become exercisable in two annual installments beginning on April 25, 2021. |
5. Consists of 25,000 vested and exercisable options as of February 8, 2021 and 25,000 options that vest and become exercisable in two annual installments beginning on February 8, 2022. |
6. Consists of 1,150 vested and exercisable options as of February 8, 2021 and 1,151 options that vest and become exercisable in two annual installments beginning on February 8, 2022. |
7. These options vest and become exercisable in four annual installments beginning on May 8, 2021. |
Remarks: |
For Christopher Armstrong, pursuant to the Power of Attorney previously filed. |
/s/ William E. McDonald, attorney-in-fact | 03/01/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |